Richard F. Camalier

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Susan L. Holbeck, Richard F. Camalier, James A. Crowell et al. · Cancer Research · 2017 · 392 citations · Full text

Medicine, Oncology, Pharmacology +12

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

Brian K. Adams, Eva Ferstl, Matthew C. Davis et al. · Bioorganic & Medicinal Chemistry · 2004 · 390 citations

Medicine, Medicinal Chemistry, Oncology +15

In vivo cultivation of tumor cells in hollow fibers

Melinda G. Hollingshead, Michael C. Alley, Richard F. Camalier et al. · Life Sciences · 1995 · 344 citations

Engineering, Bioengineering, Biomedical Engineering +16

Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models

Victoria Smith, Edward A. Sausville, Richard F. Camalier et al. · Cancer Chemotherapy and Pharmacology · 2005 · 156 citations

Medicine, Medicinal Chemistry, Oncology +6

Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product

Gurmeet Kaur, Melinda G. Hollingshead, Susan L. Holbeck et al. · Biochemical Journal · 2006 · 130 citations · Full text

Medicine, Oncology, Pharmacology +13